Study to Evaluate 99mTc-MIP-1404 SPECT/CT Imaging in Men With Biopsy Proven Low-Grade Prostate Cancer

Clinical trial NCT02615067 · COMPLETED

Trial details

NCT number: NCT02615067
Sponsor: Molecular Insight Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2015-12-01
Primary completion: 2017-12-28
Enrollment: 531

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.